Stay updated on Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision tag was updated to v3.5.4, representing a minor update to the study record rather than a substantive change to its content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedUpdated the Chile site’s location labeling (Araucania/Temuco) by replacing Spanish “Región de la Araucanía” wording with “Araucania,” and updated the page’s revision footer from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check108 days agoChange DetectedRevision: v3.4.2 was added and the previous funding-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.